FDA asks drugmaker Eli Lilly for more safety information on its new GLP-1 weight loss pill
- Postato il 15 aprile 2026
- Di The Independent
- 0 Visualizzazioni
FDA asks drugmaker Eli Lilly for more safety information on its new GLP-1 weight loss pill
At the heart of the request is whether taking Foundayo - made with a new active ingredient called orforglipron - could be linked to liver, heart and gastrointestinal problems
